AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published August 7, 2008

American Journal of Neuroradiology 2008;29:1867.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1242v1
29/10/1867    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, T.
Right arrow Articles by Iwama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, T.
Right arrow Articles by Iwama, T.

American Journal of Neuroradiology
DOI 10.3174/ajnr.A1242

BRAIN

Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity

T. Kato, J. Shinoda, N. Oka, K. Miwa, N. Nakayama, H. Yano, T. Maruyama, Y. Muragaki and T. Iwama

From the Chubu Medical Center for Prolonged Traumatic Brain Dysfunction (T.K., J.S., N.O., K.M.), Kizawa Memorial Hospital, Minokamo City, Gifu, Japan; Department of Neurosurgery (T.K., N.N., H.Y., T.I.), Gifu University Graduate School of Medicine, Gifu, Japan; and Department of Neurosurgery (T.M., Y.M.), Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan.

Please address correspondence to Takayuki Kato, MD, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital, 630 Shimokobi, Kobi-machi, Minokamo City, Gifu, Japan 505-0034; e-mail: ttaka1010{at}gmail.com

BACKGROUND AND PURPOSE: The relationship of 11C-methionine (MET) uptake and tumor activity in low-grade gliomas (those meeting the criteria for World Health Organization [WHO] grade II gliomas) remains uncertain. The aim of this study was to compare MET uptake in low-grade gliomas and to analyze whether MET positron-emission tomography (PET) can estimate tumor viability and provide evidence of malignant transformation.

MATERIALS AND METHODS: We studied glioma metabolic activity in 49 consecutive patients with newly diagnosed grade II gliomas by using MET PET before surgical resection. On MET PET, we measured tumor/normal brain uptake ratio (T/N ratio) in 21 diffuse astrocytomas (DAs), 12 oligodendrogliomas (ODs), and 16 oligoastrocytomas (OAs). We compared MET T/N ratio among these 3 tumors and investigated possible correlation with proliferative activity, as measured by Mib-1 labeling index (LI).

RESULTS: MET T/N ratios of DA, OD, and OA were 2.11 ± 0.87, 3.75 ± 1.43, and 2.76 ± 1.27, respectively. The MET T/N ratio of OD was significantly higher than that of DA (P < .005). In comparison of MET T/N ratios with the Mib-1 LI, a significant correlation was shown in DA (r = 0.63; P < .005) but not in OD and OA.

CONCLUSION: MET uptake in DAs may be closely associated with tumor viability, which depends on increased amino acid transport by an activated carrier-mediated system. DAs with lower MET uptake were considered more quiescent lesions, whereas DA with higher MET uptake may act more aggressively.




This article has been cited by other articles:


Home page
 JNMHome page
B. J. Lopresti and N. S. Mason
2-18F-Fluoroacetate: A Useful Tool for Assessing Gliosis in the Central Nervous System?
J. Nucl. Med., June 1, 2009; 50(6): 841 - 843.
[Full Text] [PDF]


Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X